Phathom Pharmaceuticals, Inc. (PHAT) short interest & options flow
NASDAQPhathom Pharmaceuticals heads into its October 29 earnings report down 28% over the past month, with short sellers retreating slightly but the stock's own history giving bears plenty to work with. The most telling number in the positioning picture is the earnings track record. Last quarter, the stock fell nearly 25% on the day of results and continued sliding to a five-day loss of…
- Market cap
- $417M
- Next earnings
- 4 Mar 2027
Key data as of 7 Nov 2026

PHAT news and analysis
RSSNo long-form analysis yet for PHAT. Pulse alerts and the live data picture are available on ORTEX.
Open PHAT on ORTEX →Want the live picture for PHAT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PHAT — free to start on ORTEX.
Sign up for free →Open PHAT on ORTEX